MR Imaging and Localized Proton Spectroscopy of the Precentral Gyrus in Amyotrophic Lateral Sclerosis

References

1. ↵
   Nelson LM. Epidemiology of ALS. Clin Neurosci 1996;3:327-331

   CrossRef
2. ↵
   Leigh PN. Pathogenic mechanisms in amyotrophic lateral sclerosis and other motor neuron disorders. In: Calne DB, ed Neurodegenerative Diseases Philadelphia: Saunders; 1993:473-488
3. ↵
   Brooks BR, Antel J, Bradley WG. El Escorial World Federation of Neurology Criteria for the diagnosis of amyotrophic lateral sclerosis. Neurol Sci 1994;124:96-107
4. ↵
   Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993;189:843-846

   CrossRefPubMedWeb of Science
5. ↵
   Cheung G, Gawel MJ, Cooper PW, et al. Amyotrophic lateral sclerosis: correlation of clinical and MR imaging findings. Radiology 1995;194:263-270

   CrossRefPubMedWeb of Science
6. Hofman E, Ochs G, Pelzl A, Warmuth-Methz M. The corticospinal tract in amyotrophic lateral sclerosis: an MRI study. Neuroradiology 1998;40:71-75

   CrossRefPubMedWeb of Science
7. ↵
   Waragai M. MRI and clinical features in amyotrophic lateral sclerosis. Neuroradiology 1997;39:847-851

   CrossRefPubMedWeb of Science
8. ↵
   Hajnal JV, Bryant DJ, Kasuboski L, et al. Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain. J Comput Assist Tomogr 1992;16:841-844

   CrossRefPubMedWeb of Science
9. ↵
   Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology 1994;44:1933-1938

   Abstract/FREE Full Text
10. Jones AP, Gunawardena WJ, Coutinho CM, et al. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amyotrophic lateral sclerosis). J Neurol Sci 1995;129: Suppl: 85-89

    CrossRefPubMed
11. ↵
    Block W, Karitzky J, Traber F, et al. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 1998;55:931-366

    CrossRefPubMedWeb of Science
12. ↵
    Rooney WD, Miller RG, Gelinas D, et al. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 1998;50:1800-1805

    Abstract/FREE Full Text
13. ↵
    Gredal O, Rosenbaum S, Topp S, et al. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 1997;48:878-881

    Abstract/FREE Full Text
14. ↵
    Hammer RP Jr, Tomiyasu U, Scheibel AB. Degeneration of the human Betz cell due to amyotrophic lateral sclerosis. Exp Neurol 1979;63:336-346

    CrossRefPubMedWeb of Science
15. ↵
    Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic pathway for neurologic disorders. N Engl J Med 1994;330:613-622

    CrossRefPubMedWeb of Science
16. ↵
    Rothstein JD. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis. Clin Neurosci 1996;3:348-359

    Web of Science
17. Mitsumoto H, Chad DA, Pioro EP. Excitotoxicity and oxidative damage in ALS pathogenesis. In: Amyotrophic Lateral Sclerosis. Philadelphia: Davis; 1998:197-225
18. ↵
    Haselgrove JC, Subramanian VH, Christen R, Leigh JS. Analysis of in-vivo NMR spectra. Rev Magn Reson Med 1987;2:167-222
19. Bowen BC, Block RE, Sanchez-Ramos J, et al. Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR Am J Neuroradiol 1995;16:61-68

    Abstract
20. ↵
    Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679

    CrossRefPubMedWeb of Science
21. ↵
    Michaelis T, Merboldt K-D, Bruhn H, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993;187:219-227

    CrossRefPubMedWeb of Science
22. ↵
    Pouwels PJW, Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998;39:53-60

    CrossRefPubMedWeb of Science
23. ↵
    Pioro EP. MR spectroscopy in amyotrophic lateral sclerosis/motor neuron disease. J Neurol Sci 1997;152(Suppl 1):S49-S53
24. ↵
    Naidich TP, Grant JL, Altman N, et al. The developing cerebral surface: preliminary report on the patterns of sulcal and gyral maturation—anatomy, ultrasound and magnetic resonance imaging. Neuroimaging Clin N Am 1994;4:201-240

    PubMed
25. ↵
    Klose U. In vivo proton spectroscopy in the presence of eddy currents. Magn Reson Med 1990;14:26-30

    CrossRefPubMedWeb of Science
26. ↵
    Miller BL. A review of chemical issues in 1H NMR spectroscopy: N-acetyl->/SCAP<L-aspartate, creatine and choline. NMR Biomed 1991;4:47-52

    PubMedWeb of Science
27. ↵
    Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990;28:18-25

    CrossRefPubMedWeb of Science
28. ↵
    Tsai G, Stauch-Slusher B, Sim L, et al. Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS. Brain Res 1991;556:151-156

    CrossRefPubMedWeb of Science
29. ↵
    Kalra S, Cashman NR, Genge A, Arnold DL. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 1998;9:1757-1761

    CrossRefPubMedWeb of Science
30. ↵
    Ikeda K, Iwasaki Y, Kinoshita M, et al. Quantification of brain metabolites in ALS by localized proton magnetic spectroscopy (letter). Neurology 1998;50:576-577

    FREE Full Text
31. ↵
    Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain. Magn Reson Med 1995;33:755-759

    CrossRefPubMedWeb of Science
32. ↵
    Petroff OA, Spencer DD, Alger JR, Prichard JW. High-field proton magnetic resonance spectroscopy of human cerebrum obtained during surgery for epilepsy. Neurology 1989;39:1197-1202

    Abstract/FREE Full Text
33. ↵
    Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999;5:347-350

    CrossRefPubMedWeb of Science
34. ↵
    Roser W, Hagberg G, Mader I, et al. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter. Magn Reson Med 1995;33:811-817

    PubMedWeb of Science
35. Chang L, Miller BL, McBride D, et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995;197:525-531

    CrossRefPubMedWeb of Science
36. ↵
    Dal Canto MC. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications. Clin Neurosci 1996;3:332-337
37. Nagy D, Kato T, Kushner PD. Reactive astrocytes are widespread in the cortical gray matter of amyotrophic lateral sclerosis. J Neurosci Res 1994;38:336-347

    CrossRefPubMedWeb of Science
38. Kushner PD, Stephenson DT, Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J Neuropathol Exp Neurol 1991;50:263-277

    CrossRefPubMed
39. ↵
    Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993;15:289-298

    CrossRefPubMedWeb of Science
40. ↵
    Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of cerebral metabolites. Neuropediatrics 1996;27:64-69

    CrossRefPubMedWeb of Science
41. ↵
    Michaelis T, Merboldt K-D, Hanicke W, et al. On the identification of cerebral metabolites in localized 1H NMR spectra of human brain in vivo. NMR Biomed 1991;4:90-98

    CrossRefPubMedWeb of Science
42. ↵
    Plaitakis A. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis. Ann Neurol 1990;28:3-8

    CrossRefPubMedWeb of Science
43. Rothstein JD, Kuncl R, Chaudhry V. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neurol 1991;30:224-225

    CrossRefPubMedWeb of Science
44. Perry TL, Hansen S, Jones K. Brain glutamate deficiency in amyotrophic lateral sclerosis. Neurology 1987;37:1845-1848

    Abstract/FREE Full Text
45. Plaitakis A, Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Brain Res Bull 1993;30:381-386

    CrossRefPubMed
46. ↵
    Kvamme E, Schousboe A, Hertz L, et al. Developmental change of endogenous glutamate and gamma-glutamyl transferase in cultured cerebral cortical interneurons and cerebellar granule cells, and in mouse cerebral cortex and cerebellum in vivo. Neurochem Res 1985;10:993-1008

    CrossRefPubMedWeb of Science
47. ↵
    Drayer BP. Imaging of the aging brain: II, pathologic conditions. Radiology 1988;166:797-806

    CrossRefPubMedWeb of Science
48. ↵
    Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203:829-836

    CrossRefPubMedWeb of Science
49. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998;50:72-77

    Abstract/FREE Full Text